Drug companies like Eli Lilly and Roche are racing to build supercomputers to help fix the 90% failure rate in drug ...

The research and development of new pharmaceuticals is increasingly an international affair, something that recent discussion about how tariffs might affect drug prices has made very clear. And even ...

Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.

The US Food and Drug Administration has published a final guidance and two draft guidances that detail its thinking on developing certain types of new cancer drugs. The guidances are meant to provide ...

Stakeholders urged the US Food and Drug Administration (FDA) to broaden the scope of its guidance on developing drugs for acute radiation syndrome (ARS) to treat downstream exposure, while one group ...

By Puyaan Singh and Christy Santhosh April 30 (Reuters) - Companies developing cannabis-based medicines say U.S. moves to ...

Oxana Iliach is a Senior Director of Regulatory Strategy at Certara (PA, USA), a biotech company that offers comprehensive solutions for transforming and accelerating drug development. In her spare ...

Competition to create new brand-name drugs is a key driver of innovation in the United States. Unfortunately, it also drives the relentless growth of healthcare spending. That’s because development of ...

With few treatments available to stop or reverse Alzheimer’s disease, scientists have turned to cancer drugs as a potential means of walking back cognitive decline. Alzheimer’s cases are rising in the ...